Amedeo Smart

Free Medical Literature Service

 

Amedeo

Obstructive Lung Diseases
  Free Subscription

Articles published in
Allergy
    April 2024
  1. AGACHE I, Annesi-Maesano I, Cecchi L, Biagioni B, et al
    EAACI guidelines on environmental science for allergy and asthma: The impact of short-term exposure to outdoor air pollutants on asthma-related outcomes and recommendations for mitigation measures.
    Allergy. 2024 Apr 2. doi: 10.1111/all.16103.
    >> Share

    March 2024

  2. Correction to Long-term immune response accompanies clinical outcomes in severe asthmatics treated with anti-IL-5/IL-5R biologics.
    Allergy. 2024 Mar 12. doi: 10.1111/all.16081.
    >> Share

  3. JUTEL M, Klimek L, Richter H, Bruggenjurgen B, et al
    House dust mite SCIT reduces asthma risk and significantly improves long-term rhinitis and asthma control-A RWE study.
    Allergy. 2024 Mar 2. doi: 10.1111/all.16052.
    >> Share

  4. OKUNISHI K, Kochi Y, Zhao M, Wang H, et al
    Munc13-4 regulates asthma and obesity in mice by controlling functions of CD11c(+) antigen-presenting cells.
    Allergy. 2024 Mar 1. doi: 10.1111/all.16087.
    >> Share

    February 2024
  5. CARUSO C, Ciasca G, Baglivo I, Di Santo R, et al
    Immunoglobulin free light chains in severe asthma patient: Could they be a new biomarker?
    Allergy. 2024 Feb 29. doi: 10.1111/all.16082.
    >> Share

  6. NADIF R, Henny J, Tsiavia T, Ribet C, et al
    Blood basophils and asthma among participants from CONSTANCES, the French population-based cohort.
    Allergy. 2024 Feb 29. doi: 10.1111/all.16093.
    >> Share

  7. CHEN X, He YQ
    Correspondence to "intranasal administration of Acinetobacter lwoffii in a murine model of asthma induces IL-6-mediated protection associated with cecal microbiota changes".
    Allergy. 2024 Feb 25. doi: 10.1111/all.16075.
    >> Share

  8. OKADA N, Oguma T, Asano K
    Reply to Correspondence to "Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma-factor analysis".
    Allergy. 2024 Feb 21. doi: 10.1111/all.16074.
    >> Share

  9. DEL DUCA E, Dahabreh D, Kim M, Bar J, et al
    Transcriptomic evaluation of skin tape-strips in children with allergic asthma uncovers epidermal barrier dysfunction and asthma-associated biomarkers abnormalities.
    Allergy. 2024 Feb 20. doi: 10.1111/all.16060.
    >> Share

  10. NI D, Senior AM, Raubenheimer D, Simpson SJ, et al
    Global associations of macronutrient supply and asthma disease burden.
    Allergy. 2024 Feb 19. doi: 10.1111/all.16067.
    >> Share

  11. DEVILLIERS MA, Brisebarre A, Petit LMG, Polette M, et al
    Airway epithelial cell cilia transcriptomic dysregulation is associated with the inflammatory phenotype in asthma.
    Allergy. 2024 Feb 19. doi: 10.1111/all.16063.
    >> Share

  12. AGACHE I, Canelo-Aybar C, Annesi-Maesano I, Cecchi L, et al
    The impact of indoor pollution on asthma-related outcomes: A systematic review for the EAACI guidelines on environmental science for allergic diseases and asthma.
    Allergy. 2024 Feb 17. doi: 10.1111/all.16051.
    >> Share

  13. MORTZ CG, Parke L, Rasmussen HM, Kjaer HF, et al
    A randomized, double-blind placebo-controlled study on the efficacy of Omalizumab on food allergy threshold in children with severe food allergy.
    Allergy. 2024 Feb 17. doi: 10.1111/all.16046.
    >> Share

  14. SANTOS AF
    Is there a direct link between skin barrier dysfunction and asthma?
    Allergy. 2024 Feb 13. doi: 10.1111/all.16055.
    >> Share

  15. FARHAN AJ, Kothalawala DM, Kurukulaaratchy RJ, Granell R, et al
    Response to correspondence: Prediction of adult asthma risk in early childhood using novel adult asthma predictive risk scores.
    Allergy. 2024 Feb 13. doi: 10.1111/all.16059.
    >> Share

  16. ODLING M, Lagercrantz B, Goksor E, Sandelowsky H, et al
    Transitional care of adolescents and young adults with asthma and allergy-The healthcare professional perspective.
    Allergy. 2024 Feb 9. doi: 10.1111/all.16047.
    >> Share

  17. RICK EM, Woolnough K, Richardson M, Monteiro W, et al
    Identification of allergens from Aspergillus fumigatus-Potential association with lung damage in asthma.
    Allergy. 2024 Feb 9. doi: 10.1111/all.16032.
    >> Share

  18. AGACHE I, Canelo-Aybar C, Annesi-Maesano I, Cecchi L, et al
    The impact of outdoor pollution and extreme temperatures on asthma-related outcomes: A systematic review for the EAACI guidelines on environmental science for allergic diseases and asthma.
    Allergy. 2024 Feb 4. doi: 10.1111/all.16041.
    >> Share

  19. OKUBO H, Nakayama SF, Ohya Y
    Periconceptional maternal diet quality and offspring wheeze trajectories: Japan Environment and Children's Study.
    Allergy. 2024;79:393-403.
    >> Share

  20. PAPADOPOULOS NG, Akdis CA, Akdis M, Damialis A, et al
    Addressing adverse synergies between chemical and biological pollutants at schools-The 'SynAir-G' hypothesis.
    Allergy. 2024;79:294-301.
    >> Share

    January 2024
  21. ALHAMDAN F, Potaczek DP, Greulich T, Tost J, et al
    Reply to correspondence "Extracellular vesicle microRNA signatures as novel biomarkers in obese asthmatics".
    Allergy. 2024 Jan 29. doi: 10.1111/all.16042.
    >> Share

  22. SMILNAK GJ, Lee Y, Chattopadhyay A, Wyss AB, et al
    Plasma protein signatures of adult asthma.
    Allergy. 2024 Jan 23. doi: 10.1111/all.16000.
    >> Share

  23. FARDIG M, Hoyer A, Almqvist C, Bains KES, et al
    Infant lung function and early skin barrier impairment in the development of asthma at age 3 years.
    Allergy. 2024 Jan 18. doi: 10.1111/all.16024.
    >> Share

  24. CHANG KY, Lu CT, Yii CY, Yong SB, et al
    Correspondence to "Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma-Factor analysis".
    Allergy. 2024 Jan 16. doi: 10.1111/all.16016.
    >> Share

  25. ZHANG D, Zhang J, Xu C, Qi Q, et al
    A humanized mouse model to study asthmatic airway remodeling and Muc-5ac secretion via the human IL-33.
    Allergy. 2024 Jan 16. doi: 10.1111/all.16030.
    >> Share

  26. WON J, Jo A, Kim S, Shin H, et al
    Distinct dampening of IL-33 following inhalation of interferon-lambda in the respiratory epithelium of in vivo asthma.
    Allergy. 2024 Jan 11. doi: 10.1111/all.16010.
    >> Share

  27. HEKKING PP, Zhang K, Garrido CPV, Lopez-Rodriguez R, et al
    Sputum cytokines associated with raised FeNO after anti-IL5 biologic therapy in severe asthma.
    Allergy. 2024 Jan 10. doi: 10.1111/all.16011.
    >> Share

  28. KIMURA Y, Suzukawa M, Jo T, Hashimoto Y, et al
    Epidemiology of severe childhood asthma in Japan: A nationwide descriptive study.
    Allergy. 2024 Jan 7. doi: 10.1111/all.16008.
    >> Share

  29. PEREZ DE LLANO L, Urrutia I, G Cosio B, Gullon-Blanco JA, et al
    Impact of comorbidities on the achievement of specific therapeutic goals in biologic-treated asthma patients.
    Allergy. 2024 Jan 5. doi: 10.1111/all.15999.
    >> Share

  30. VOSKAMP AL, de Jong NW, Jochems SP, Ozir-Fazalalikhan A, et al
    Early expansion of allergen-responsive LAP(+) B regulatory cells in allergic rhinitis but not in allergic asthma subjects during allergen immunotherapy.
    Allergy. 2024 Jan 3. doi: 10.1111/all.15973.
    >> Share

  31. NOPSOPON T, Barrett NA, Phipatanakul W, Laidlaw TM, et al
    Lung function trajectories in a cohort of patients with moderate-to-severe asthma on mepolizumab, omalizumab, or dupilumab.
    Allergy. 2024 Jan 2. doi: 10.1111/all.16002.
    >> Share

    December 2023
  32. CAMINATI M, Buhl R, Corren J, Hanania NA, et al
    Tezepelumab in patients with allergic and eosinophilic asthma.
    Allergy. 2023 Dec 26. doi: 10.1111/all.15986.
    >> Share

  33. HAMELMANN E, Hammerby E, Scharling KS, Pedersen M, et al
    Quantifying the benefits of early sublingual allergen immunotherapy tablet initiation in children.
    Allergy. 2023 Dec 26. doi: 10.1111/all.15985.
    >> Share

  34. LEE E, Rhee EH, Yu J, Kim K, et al
    Incidence of healthcare utilization for allergic and respiratory infectious diseases in children with asthma before and during the COVID-19 pandemic.
    Allergy. 2023 Dec 23. doi: 10.1111/all.15992.
    >> Share

  35. SUNDAR IK, Prasad C, Duraisamy SK
    Extracellular vesicle microRNA signatures as novel biomarkers in obese asthmatics.
    Allergy. 2023 Dec 21. doi: 10.1111/all.15979.
    >> Share

  36. SCHWARTZ BS, Hirsch AG, Bandeen-Roche K, Kato A, et al
    Reply to "correspondence to 'association between chronic rhinosinusitis and new onset asthma implications for prevention'".
    Allergy. 2023 Dec 14. doi: 10.1111/all.15984.
    >> Share

  37. CHENG I, Yii CY, Shih LC, Wang JY, et al
    Correspondence to 'association between chronic rhinosinusitis and new onset asthma implications for prevention'.
    Allergy. 2023 Dec 1. doi: 10.1111/all.15965.
    >> Share

  38. SMOLINSKA S, Popescu FD, Izquierdo E, Antolin-Amerigo D, et al
    Telemedicine with special focus on allergic diseases and asthma-Status 2022: An EAACI position paper.
    Allergy. 2023 Dec 1. doi: 10.1111/all.15964.
    >> Share

  39. NUNOMURA S, Ito R, Nanri Y, Ohno Y, et al
    Novel mechanisms by which benralizumab suppresses IgE expression in human B cells in humanized mice.
    Allergy. 2023;78:3271-3273.
    >> Share

  40. SULLIVAN MO, Curtin M, Flynn R, Cronin C, et al
    Telehealth interventions for transition to self-management in adolescents with allergic conditions: A systematic review.
    Allergy. 2023 Dec 1. doi: 10.1111/all.15963.
    >> Share

    November 2023
  41. PHAM DD, Hong C, Lee JH, Kwon HS, et al
    Longitudinal asthma phenotypes by multi-trajectory analysis.
    Allergy. 2023 Nov 29. doi: 10.1111/all.15958.
    >> Share

  42. CHEN Y, Checa A, Zhang P, Huang M, et al
    Sphingolipid classes and the interrelationship with pediatric asthma and asthma risk factors.
    Allergy. 2023 Nov 28. doi: 10.1111/all.15942.
    >> Share

  43. SCHMID-GRENDELMEIER P, Gooderham MJ, Hartmann K, Konstantinou GN, et al
    Efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis and comorbid allergies.
    Allergy. 2023 Nov 21. doi: 10.1111/all.15952.
    >> Share

  44. TRAN NQV, Le MK, Nakamura Y, Kondo T, et al
    A link between KIT expression, mast cell abundance and activity, and Th2-high endotype in asthmatic airways.
    Allergy. 2023 Nov 20. doi: 10.1111/all.15954.
    >> Share

  45. LINDQVIST M, Leth-Moller KB, Linneberg A, Kull I, et al
    Natural course of pollen-induced allergic rhinitis from childhood to adulthood: A 20-year follow up.
    Allergy. 2023 Nov 2. doi: 10.1111/all.15927.
    >> Share

    October 2023
  46. CAMINATI M, Fassio A, Alberici F, Baldini C, et al
    Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group.
    Allergy. 2023 Oct 31. doi: 10.1111/all.15934.
    >> Share

  47. SAARIMAKI L, Kivisto J, Palmu S, Protudjer JLP, et al
    Trends in severe allergic reactions of adults in Finland between 1999 and 2020: A national population study.
    Allergy. 2023 Oct 30. doi: 10.1111/all.15929.
    >> Share

  48. GAUTAM S, Chu JH, Cohen AJ, Kaur R, et al
    Sputum alarmins delineate distinct T2 cytokine pathways and unique subtypes of patients with asthma.
    Allergy. 2023 Oct 24. doi: 10.1111/all.15915.
    >> Share

  49. SVERRILD A, Cerps S, Nieto-Fontarigo JJ, Ramu S, et al
    Tezepelumab decreases airway epithelial IL-33 and T2-inflammation in response to viral stimulation in patients with asthma.
    Allergy. 2023 Oct 17. doi: 10.1111/all.15918.
    >> Share

  50. KIM JH, Lee E, Ha EK, Shin J, et al
    Cascade of atopic dermatitis comorbidities in children after birth for 15 years.
    Allergy. 2023 Oct 16. doi: 10.1111/all.15917.
    >> Share

  51. VULTAGGIO A, Accinno M, Vivarelli E, Mecheri V, et al
    Blood CD62L(low) inflammatory eosinophils are related to the severity of asthma and reduced by mepolizumab.
    Allergy. 2023 Oct 4. doi: 10.1111/all.15909.
    >> Share

  52. VAN DER LANS RJL, Otten JJ, Adriaensen GFJPM, Hoven DR, et al
    Two-year results of tapered dupilumab for CRSwNP demonstrates enduring efficacy established in the first 6 months.
    Allergy. 2023;78:2684-2697.
    >> Share

    September 2023
  53. SVENNINGSEN S, Kjarsgaard M, Zhang K, Serajeddini H, et al
    Effect of dupilumab on sputum eosinophils in patients with moderate-to-severe asthma.
    Allergy. 2023 Sep 26. doi: 10.1111/all.15901.
    >> Share

  54. JIA M, Fu H, Jiang X, Wang L, et al
    DEL-1, as an anti-neutrophil transepithelial migration molecule, inhibits airway neutrophilic inflammation in asthma.
    Allergy. 2023 Sep 8. doi: 10.1111/all.15882.
    >> Share

  55. LU C, Wang F, Qiao Z, Deng M, et al
    Extreme temperatures exacerbated oxidative stress and airway inflammation in a mouse model of allergic asthma.
    Allergy. 2023 Sep 7. doi: 10.1111/all.15883.
    >> Share

  56. FARHAN AJ, Kothalawala DM, Kurukulaaratchy RJ, Granell R, et al
    Prediction of adult asthma risk in early childhood using novel adult asthma predictive risk scores.
    Allergy. 2023 Sep 3. doi: 10.1111/all.15876.
    >> Share

    August 2023
  57. GUILLEMINAULT L, Villeneuve T, Didier A, Reber LL, et al
    Maintained effect of endoscopic sinus surgery in asthma responders to drugs targeting the IL5 pathway with persistent nasal polyposis.
    Allergy. 2023 Aug 31. doi: 10.1111/all.15874.
    >> Share

  58. LORENTE-SOROLLA C, Bernaola J, Sanchez-Mellado D, Gil-Martinez M, et al
    Long-term immune response accompanies clinical outcomes in severe asthmatics treated with anti-IL-5/IL-5R biologics.
    Allergy. 2023 Aug 29. doi: 10.1111/all.15872.
    >> Share

  59. THOMAS D, McDonald VM, Stevens S, Harvey ES, et al
    Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients.
    Allergy. 2023 Aug 25. doi: 10.1111/all.15867.
    >> Share

  60. ALVARADO-VAZQUEZ PA, Mendez-Enriquez E, Salomonsson M, Waern I, et al
    Circulating mast cell progenitors increase during natural birch pollen exposure in allergic asthma patients.
    Allergy. 2023 Aug 24. doi: 10.1111/all.15860.
    >> Share

    July 2023
  61. ADAM T, Divaret-Chauveau A, Roduit C, Adel-Patient K, et al
    Complementary feeding practices are related to the risk of food allergy in the ELFE cohort.
    Allergy. 2023 Jul 26. doi: 10.1111/all.15828.
    >> Share

  62. ALHAMDAN F, Greulich T, Daviaud C, Marsh LM, et al
    Identification of extracellular vesicle microRNA signatures specifically linked to inflammatory and metabolic mechanisms in obesity-associated low type-2 asthma.
    Allergy. 2023 Jul 24. doi: 10.1111/all.15824.
    >> Share

  63. KORTEKAAS KROHN I, Badloe FMS, Herrmann N, Maintz L, et al
    Immunoglobulin E autoantibodies in atopic dermatitis associate with Type-2 comorbidities and the atopic march.
    Allergy. 2023 Jul 24. doi: 10.1111/all.15822.
    >> Share

  64. YANG X, Zhao J, Sima Y, Zhao Y, et al
    The association between allergic rhinitis and the risk of coronavirus disease 2019 (COVID-19): A national survey in China.
    Allergy. 2023 Jul 21. doi: 10.1111/all.15823.
    >> Share

  65. OKADA N, Yamamoto Y, Oguma T, Tanaka J, et al
    Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma-Factor analysis.
    Allergy. 2023 Jul 17. doi: 10.1111/all.15820.
    >> Share

  66. CHEN T, Shi S, Li X, Zhou L, et al
    Improved ambient air quality is associated with decreased prevalence of childhood asthma and infancy shortly after weaning is a sensitive exposure window.
    Allergy. 2023 Jul 17. doi: 10.1111/all.15815.
    >> Share

  67. KAPPEN J, Diamant Z, Agache I, Bonini M, et al
    Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma: An EAACI position paper.
    Allergy. 2023 Jul 14. doi: 10.1111/all.15817.
    >> Share

  68. PAVORD ID, Bourdin A, Papi A, Domingo C, et al
    Dupilumab sustains efficacy in patients with moderate-to-severe type 2 asthma regardless of ICS dose.
    Allergy. 2023 Jul 11. doi: 10.1111/all.15792.
    >> Share

  69. SHIN YH, Hwang J, Kwon R, Lee SW, et al
    Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019.
    Allergy. 2023 Jul 11. doi: 10.1111/all.15807.
    >> Share

  70. MUBANGA M, Brew BH, Karim H, Curman P, et al
    Maternal body mass index in pregnancy and offspring asthma and food allergy.
    Allergy. 2023 Jul 5. doi: 10.1111/all.15803.
    >> Share

  71. THARAKAN A, Kumar A, Allegood J, Cowart LA, et al
    D-2-hydroxyglutarate suppresses allergic sensitization in a murine model of experimental asthma.
    Allergy. 2023 Jul 5. doi: 10.1111/all.15809.
    >> Share

    June 2023
  72. KIM SH, Kim SP, Song JI, Kim Z, et al
    Causal relationship between asthma outpatient visits and air pollution with instrumental variable approach.
    Allergy. 2023 Jun 26. doi: 10.1111/all.15791.
    >> Share

  73. SCHLEICH F, Maury E, Bachert C, Hanon S, et al
    Epidemiology of sensitization to perennial aeroallergens in adults with severe asthma in Belgium. The BEIgE study.
    Allergy. 2023 Jun 21. doi: 10.1111/all.15785.
    >> Share

  74. PRICE OJ, Del Giacco S, Gawlik R, Janson C, et al
    Exercise and physical activity for asthma management: The European Academy of Allergy and Clinical Immunology perspective.
    Allergy. 2023 Jun 20. doi: 10.1111/all.15789.
    >> Share

  75. VERSI A, Ivan FX, Abdel-Aziz MI, Bates S, et al
    Haemophilus influenzae and Moraxella catarrhalis in sputum of severe asthma with inflammasome and neutrophil activation.
    Allergy. 2023 Jun 7. doi: 10.1111/all.15776.
    >> Share

    May 2023
  76. SOHN KH, Choi S, Jung JW, Choi JH, et al
    Different inflammatory features of asthma according to gut microbiome enterotype.
    Allergy. 2023 May 18. doi: 10.1111/all.15768.
    >> Share

  77. SCHWARTZ BS, Pollak JS, Bandeen-Roche K, Hirsch AG, et al
    Sinus inflammation and chronic rhinosinusitis are associated with a diagnosis of new onset asthma in the following year.
    Allergy. 2023 May 17. doi: 10.1111/all.15771.
    >> Share

  78. XU E, Cao G, Yang Z, Zhang Y, et al
    Adventitial stromal cells and myofibroblasts recruit pro- and anti- inflammatory immune cells in allergic airway inflammation.
    Allergy. 2023 May 12. doi: 10.1111/all.15766.
    >> Share

  79. ROVIRA RUBIO J, Megremis S, Pasioti M, Lakoumentas J, et al
    Respiratory virome profiles reflect antiviral immune responses.
    Allergy. 2023;78:1258-1268.
    >> Share

  80. LICCARDI G, Bilo MB, Calzetta L, Milanese M, et al
    Pest sensitization to cockroach, mouse, and rat: An Italian multicenter study.
    Allergy. 2023;78:1360-1363.
    >> Share

    April 2023
  81. JUTEL M, Mosnaim GS, Bernstein JA, Del Giacco S, et al
    The One Health approach for allergic diseases and asthma.
    Allergy. 2023 Apr 29. doi: 10.1111/all.15755.
    >> Share

  82. DENTON E, O'Hehir RE, Hew M
    The changing global prevalence of asthma and atopic dermatitis.
    Allergy. 2023 Apr 27. doi: 10.1111/all.15754.
    >> Share

  83. RABE KF, Pavord ID, Busse WW, Chupp GL, et al
    Dupilumab Improves Long-term Outcomes in Patients With Uncontrolled, Moderate-to-Severe GINA-Based Type 2 Asthma, Irrespective of Allergic Status.
    Allergy. 2023 Apr 19. doi: 10.1111/all.15747.
    >> Share

  84. PAPADOPOULOS NG, Szefler SJ, Bacharier LB, Maspero JF, et al
    Assessment of dupilumab in children with moderate-to-severe type 2 asthma with or without evidence of allergic asthma.
    Allergy. 2023 Apr 14. doi: 10.1111/all.15743.
    >> Share

  85. BOUSQUET J, Shamji MH, Anto JM, Schunemann HJ, et al
    Patient-centred digital biomarkers for allergic respiratory diseases and asthma: the ARIA-EAACI approach.
    Allergy. 2023 Apr 11. doi: 10.1111/all.15740.
    >> Share

  86. YAO L, Yuan X, Fu H, Guo Q, et al
    Epithelium-derived cystatin SN inhibits HDM protease activity in allergic asthma.
    Allergy. 2023 Apr 7. doi: 10.1111/all.15739.
    >> Share

    March 2023
  87. BJORKANDER S, Maier P, Kere M, Merid SK, et al
    Innate lymphoid cells type 2 and CD8(+) T cells are perturbed in overweight and obese individuals with asthma.
    Allergy. 2023 Mar 30. doi: 10.1111/all.15728.
    >> Share

  88. ANNESI-MAESANO I, Cecchi L, Benedetta B, Chung KF, et al
    Is exposure to pollen a risk factor for moderate and severe asthma exacerbations?
    Allergy. 2023 Mar 24. doi: 10.1111/all.15724.
    >> Share

  89. SETHI GS, Gracias DT, Gupta RK, Carr D, et al
    Anti-CD3 Inhibits Circulatory and Tissue-resident Memory CD4 T Cells that Drive Asthma Exacerbations in Mice.
    Allergy. 2023 Mar 23. doi: 10.1111/all.15722.
    >> Share

  90. LIN T, Jonathan P, Denton E, Lee J, et al
    Trait profiles in difficult-to-treat asthma: clinical impact and response to systematic assessment.
    Allergy. 2023 Mar 20. doi: 10.1111/all.15719.
    >> Share

  91. YORGANCIOGLU A, Reddel HK
    Global Initiative for Asthma (GINA): 30 years of promoting evidence-based asthma care.
    Allergy. 2023 Mar 18. doi: 10.1111/all.15714.
    >> Share

  92. PFEFFER PE, Ali N, Murray R, Ulrik C, et al
    Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in patients with severe asthma eligible for both.
    Allergy. 2023 Mar 17. doi: 10.1111/all.15711.
    >> Share

  93. MOVASSAGH H, Prunicki M, Kaushik A, Zhou X, et al
    Proinflammatory polarization of monocytes by particulate air pollutants is mediated by induction of trained immunity in pediatric asthma.
    Allergy. 2023 Mar 16. doi: 10.1111/all.15692.
    >> Share

  94. JANSON C, Melen E, Licht SF, Telg G, et al
    Prescribing patterns of budesonide/formoterol maintenance and reliever therapy in patients with asthma in Sweden.
    Allergy. 2023 Mar 15. doi: 10.1111/all.15710.
    >> Share

  95. LOMMATZSCH M, Dost M, Jaishankar N, Weise M, et al
    Dupilumab treatment increases transitional B cells in severe asthma.
    Allergy. 2023 Mar 8. doi: 10.1111/all.15703.
    >> Share

  96. PEREZ DE LLANO L, Marina Malanda N, Urrutia I, Martinez-Moragon E, et al
    Factors associated with suboptimal response to monoclonal antibodies in severe asthma.
    Allergy. 2023 Mar 3. doi: 10.1111/all.15693.
    >> Share

  97. ROBB CT, Zhou Y, Felton JM, Zhang B, et al
    Metabolic regulation by prostaglandin E(2) impairs lung group 2 innate lymphoid cell responses.
    Allergy. 2023;78:714-730.
    >> Share

  98. ORSI L, Savoure M, Bousquet J, Jacquemin B, et al
    Indoor visible moulds and rhinitis in adults: The EGEA study.
    Allergy. 2023;78:864-867.
    >> Share

    February 2023
  99. HSU YT, Wu CC, Wang CC, Chung WY, et al
    BTEX exposure and its body burden pose differential risks for asthma and its phenotypic clusters.
    Allergy. 2023 Feb 28. doi: 10.1111/all.15683.
    >> Share

  100. GU BH, Choi JP, Park T, Kim AS, et al
    Adult asthma with symptomatic eosinophilic inflammation is accompanied by alteration in gut microbiome.
    Allergy. 2023 Feb 27. doi: 10.1111/all.15691.
    >> Share

  101. DOYEN V, Poirot A, Maumy-Bertrand M, Bertrand F, et al
    Induction of immunosuppressive CD39 but not the trafficking C-C chemokine receptor 4 on Treg during LAR in mite allergic asthma.
    Allergy. 2023 Feb 22. doi: 10.1111/all.15681.
    >> Share

  102. LAMANNA E, Conde E, Mougel A, Bonnefoy J, et al
    A vaccine targeting human IL-4 and IL-13 protects against asthma in humanized mice.
    Allergy. 2023 Feb 17. doi: 10.1111/all.15680.
    >> Share

  103. BOUSQUET J, Melen E, Haahtela T, Koppelman GH, et al
    Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis.
    Allergy. 2023 Feb 17. doi: 10.1111/all.15679.
    >> Share

  104. WIESE AV, Duhn J, Korkmaz RU, Quell KM, et al
    C5aR1 activation in mice controls inflammatory eosinophil recruitment and functions in allergic asthma.
    Allergy. 2023 Feb 9. doi: 10.1111/all.15670.
    >> Share

  105. KIM YH, Lim JO, Kim JS, Kim BY, et al
    Protease allergen-induced HMGB1 contributes to NLRC4 inflammasome-mediated inflammation in experimental asthma.
    Allergy. 2023 Feb 7. doi: 10.1111/all.15668.
    >> Share

  106. SHAMJI MH, Ollert M, Adcock IM, Bennett O, et al
    EAACI Guidelines on environmental science in allergic diseases and asthma - leveraging artificial intelligence and machine learning to develop a causality model in exposomics.
    Allergy. 2023 Feb 5. doi: 10.1111/all.15667.
    >> Share

  107. STIKKER BS, Hendriks RW, Stadhouders R
    Decoding the genetic and epigenetic basis of asthma.
    Allergy. 2023 Feb 2. doi: 10.1111/all.15666.
    >> Share

  108. MITAMURA Y, Akdis CA
    Single-cell analysis of allergic diseases.
    Allergy. 2023;78:346-348.
    >> Share

    January 2023
  109. ANDERSON J, Do LAH, Wurzel D, Licciardi PV, et al
    Understanding the increased susceptibility to asthma development in preterm infants.
    Allergy. 2023 Jan 31. doi: 10.1111/all.15662.
    >> Share

  110. THURMANN L, Klos M, Mackowiak SD, Bieg M, et al
    Global hypomethylation in childhood asthma identified by genome-wide DNA-methylation sequencing preferentially affects enhancer regions.
    Allergy. 2023 Jan 27. doi: 10.1111/all.15658.
    >> Share

  111. SCHULZE J, Agache I, Eguiluz-Gracia I, Trischler J, et al
    Medical algorithm: Diagnosis and treatment of house dust mite-driven allergic asthma.
    Allergy. 2023 Jan 23. doi: 10.1111/all.15654.
    >> Share

  112. POUESSEL G, Alonzo S, Divaret-Chauveau A, Dumond P, et al
    Fatal and near-fatal anaphylaxis: the Allergy-Vigilance(R) Network data (2002-2020).
    Allergy. 2023 Jan 16. doi: 10.1111/all.15645.
    >> Share

  113. LEE H, Ryu J, Chung SJ, Park DW, et al
    Overall and respiratory mortality reduction with physical activity in subjects with and without asthma.
    Allergy. 2023 Jan 5. doi: 10.1111/all.15638.
    >> Share

  114. LEE PH, Choi S, An M, Hwang D, et al
    Angiomotin and angiostatin as asthma biomarkers: implications for the regulation of airway remodeling and inflammation.
    Allergy. 2023 Jan 5. doi: 10.1111/all.15637.
    >> Share

    December 2022
  115. BAJBOUJ K, AbuJabal R, Sahnoon L, Olivenstein R, et al
    IL-5 receptor expression in lung fibroblasts: potential role in airway remodeling in asthma.
    Allergy. 2022 Dec 27. doi: 10.1111/all.15627.
    >> Share

  116. GAUVREAU GM, Bergeron C, Boulet LP, Cockcroft DW, et al
    Sounding the Alarmins - The Role of Alarmin Cytokines in Asthma.
    Allergy. 2022 Dec 4. doi: 10.1111/all.15609.
    >> Share

  117. ALHAMWE BA, Gao Z, Alhamdan F, Harb H, et al
    Intranasal administration of Acinetobacter lwoffii in a murine model of asthma induces IL-6-mediated protection associated with caecal microbiota changes.
    Allergy. 2022 Dec 2. doi: 10.1111/all.15606.
    >> Share

  118. NDIKA J, Suojalehto H, Lindstrom I, Airaksinen L, et al
    Systemic gene signature of inhaled corticosteroid treatment in allergic asthma to flour.
    Allergy. 2022 Dec 1. doi: 10.1111/all.15605.
    >> Share

  119. FORDE B, Yao L, Shaha R, Murphy S, et al
    Immunomodulation by foods and microbes: Unravelling the molecular tango.
    Allergy. 2022;77:3513-3526.
    >> Share

  120. GISLER A, Eeftens M, de Hoogh K, Vienneau D, et al
    Pollen exposure is associated with risk of respiratory symptoms during the first year of life.
    Allergy. 2022;77:3606-3616.
    >> Share

    November 2022
  121. ALVARADO-VAZQUEZ PA, Cardenas EI, Das A, Hallgren J, et al
    Depletion of Mcpt8-expressing cells reduces lung mast cells in mice with experimental asthma.
    Allergy. 2022 Nov 27. doi: 10.1111/all.15596.
    >> Share

  122. ROSENQUIST NA, Richards M, Ferber JR, Li DK, et al
    Prepregnancy Body Mass Index and Risk of Childhood Asthma.
    Allergy. 2022 Nov 27. doi: 10.1111/all.15598.
    >> Share

  123. MUSIOL S, Harris CP, Karlina R, Gostner JM, et al
    Dietary digestible carbohydrates are associated with higher prevalence of asthma in humans and with aggravated lung allergic inflammation in mice.
    Allergy. 2022 Nov 24. doi: 10.1111/all.15589.
    >> Share

  124. SUN W, Song S, Li G, Zhou L, et al
    FcRn-targeting and ROS-responsive Fedratinib-incorporated Nanoparticles Alleviate Asthma by Inducing Eosinophil Apoptosis.
    Allergy. 2022 Nov 3. doi: 10.1111/all.15575.
    >> Share

    October 2022
  125. TAN DJ, Lodge CJ, Walters EH, Lowe AJ, et al
    Biomarkers of asthma relapse and lung function decline in adults with spontaneous asthma remission: a population-based cohort study.
    Allergy. 2022 Oct 27. doi: 10.1111/all.15566.
    >> Share

  126. AKENROYE A, Zhou G, Jackson JW, Segal J, et al
    Incidence of adverse events prompting switching between biologics among adults with asthma: A retrospective cohort study.
    Allergy. 2022 Oct 26. doi: 10.1111/all.15564.
    >> Share

  127. BRADSHAW LE, Wyatt LA, Brown SJ, Haines RH, et al
    Emollients for prevention of atopic dermatitis; 5-year findings from the BEEP randomised trial.
    Allergy. 2022 Oct 19. doi: 10.1111/all.15555.
    >> Share

  128. GURDENIZ G, Kim M, Brustad N, Ernst M, et al
    Furan fatty acid metabolite in newborns predicts risk of asthma.
    Allergy. 2022 Oct 17. doi: 10.1111/all.15554.
    >> Share

  129. WALSEMANN T, Bottger M, Traidl S, Schwager C, et al
    Specific IgE against the house dust mite allergens Der p 5, 20 and 21 influences the phenotype and severity of atopic diseases.
    Allergy. 2022 Oct 14. doi: 10.1111/all.15553.
    >> Share

  130. GAO YD, Xepapadaki P, Cui YW, Stanic B, et al
    Effect of Haemophilus influenzae, Streptococcus pneumoniae and influenza vaccinations on infections, immune response, and asthma control in preschool children with asthma.
    Allergy. 2022 Oct 13. doi: 10.1111/all.15551.
    >> Share

  131. RADZIKOWSKA U, Golebski K
    Sex hormones and asthma: the role of estrogen in asthma development and severity.
    Allergy. 2022 Oct 10. doi: 10.1111/all.15548.
    >> Share

  132. VIJEYAKUMARAN M, Al Jawhri M, Fortunato J, Solomon L, et al
    Dual Activation of Estrogen Receptor Alpha and Glucocorticoid Receptor Upregulate CRTh2-Mediated Type 2 Inflammation; Mechanism Driving Asthma Severity in Women?
    Allergy. 2022 Oct 7. doi: 10.1111/all.15543.
    >> Share

  133. WATANABE M, Nakamoto K, Inui T, Sada M, et al
    Soluble ST2 enhances IL-33-induced neutrophilic and pro-type 2 inflammation in the lungs.
    Allergy. 2022;77:3137-3141.
    >> Share

    September 2022
  134. VAZQUEZ-ORTIZ M, Gore C, Alviani C, Angier E, et al
    A practical toolbox for the effective transition of adolescents and young adults with asthma and allergies - an EAACI Position paper.
    Allergy. 2022 Sep 29. doi: 10.1111/all.15533.
    >> Share

  135. ZAITSU M, Kono K, Hosokawa Y, Miyamoto M, et al
    Maternal heated tobacco product use during pregnancy and allergy in offspring.
    Allergy. 2022 Sep 29. doi: 10.1111/all.15536.
    >> Share

  136. LEE-SARWAR KA, Chen YC, Chen YY, Kozyrskyj AL, et al
    The Maternal Prenatal and Offspring Early-Life Gut Microbiome of Childhood Asthma Phenotypes.
    Allergy. 2022 Sep 15. doi: 10.1111/all.15516.
    >> Share

  137. LIANG Q, Fu J, Wang X, Liu L, et al
    circS100A11 enhances M2a macrophage activation and lung inflammation in children with asthma.
    Allergy. 2022 Sep 14. doi: 10.1111/all.15515.
    >> Share

  138. RAVANETTI L, Dekker T, Guo L, Dijkhuis A, et al
    Efficacy of FP-025, a novel Matrix metalloproteinase-12 (MMP-12) inhibitor in murine allergic asthma.
    Allergy. 2022 Sep 12. doi: 10.1111/all.15513.
    >> Share

  139. VOGELBERG C, Klimek L, Bruggenjurgen B, Jutel M, et al
    Real-world evidence for the long-term effect of allergen immunotherapy: current status on database-derived European studies.
    Allergy. 2022 Sep 8. doi: 10.1111/all.15506.
    >> Share

  140. BOURDIN A, Bommart S, Marin G, Vachier I, et al
    Obesity in women with asthma: baseline disadvantage plus greater small-airway responsiveness.
    Allergy. 2022 Sep 7. doi: 10.1111/all.15509.
    >> Share

  141. KILANOWSKI A, Thiering E, Wang G, Kumar A, et al
    Allergic disease trajectories up to adolescence: Characteristics, early-life and genetic determinants.
    Allergy. 2022 Sep 7. doi: 10.1111/all.15511.
    >> Share

  142. KOSKINEN A, Lemmetyinen R, Luukkainen A, Kankaanranta H, et al
    Season of birth affects the risk of adult-onset asthma in Finland.
    Allergy. 2022 Sep 6. doi: 10.1111/all.15504.
    >> Share

  143. ONG HH, Andiappan AK, Duan K, Lum J, et al
    Transcriptomics of rhinovirus persistence reveals sustained expression of RIG-I and interferon-stimulated genes in nasal epithelial cells in vitro.
    Allergy. 2022;77:2778-2793.
    >> Share

    August 2022
  144. MURPHY RC, Chow YH, Lai Y, Al-Shaikhly T, et al
    Identification of Mast Cell Progenitor Cells in the Airways of Individuals with Allergic Asthma.
    Allergy. 2022 Aug 29. doi: 10.1111/all.15498.
    >> Share

  145. CHAOIMH CN, Lad D, Nico C, Puppels GJ, et al
    Early initiation of short-term emollient use for the prevention of atopic dermatitis in high risk infants - the STOP AD randomised controlled trial.
    Allergy. 2022 Aug 23. doi: 10.1111/all.15491.
    >> Share

  146. BADI YE, Salcman B, Taylor A, Rana B, et al
    IL1RAP expression and the enrichment of IL-33 activation signatures in severe neutrophilic asthma.
    Allergy. 2022 Aug 20. doi: 10.1111/all.15487.
    >> Share

  147. VAZQUEZ-MERA S, Martelo-Vidal L, Miguens-Suarez P, Saavedra-Nieves P, et al
    Serum exosome inflamma-miRs are surrogate biomarkers for asthma phenotype and severity.
    Allergy. 2022 Aug 16. doi: 10.1111/all.15480.
    >> Share

  148. VARRICCHI G, Ferri S, Pepys J, Poto R, et al
    Biologics and Airway Remodeling in Severe Asthma.
    Allergy. 2022 Aug 11. doi: 10.1111/all.15473.
    >> Share

  149. CARUSO C, Colantuono S, Ciasca G, Basile U, et al
    Different aspects of severe asthma in real life: role of Staphylococcus aureus enterotoxins and correlation to comorbidities and disease severity.
    Allergy. 2022 Aug 3. doi: 10.1111/all.15466.
    >> Share

  150. MUMBY S, Kermani NZ, Garnett JP, Pavlidis S, et al
    CEACAM5 is an IL-13-regulated epithelial gene that mediates transcription in type-2 (T2) high severe asthma.
    Allergy. 2022 Aug 2. doi: 10.1111/all.15465.
    >> Share

  151. KARLINA R, Flexeder C, Musiol S, Bhattacharyya M, et al
    Differential effects of lung inflammation on insulin resistance in humans and mice.
    Allergy. 2022;77:2482-2497.
    >> Share

    July 2022
  152. PAPI A, Corren J, Castro M, Domingo C, et al
    Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate-to-severe type 2 asthma.
    Allergy. 2022 Jul 28. doi: 10.1111/all.15456.
    >> Share

  153. JEONG JS, Choi JY, Kim JS, Park SO, et al
    SARS-CoV-2 infection in severe asthma is associated with worsening of COVID-19 through respiratory NLRP3 inflammasome activation.
    Allergy. 2022 Jul 24. doi: 10.1111/all.15452.
    >> Share

  154. HE A, Chen J, Guan J, Huang Y, et al
    Selective eosinophil necroptosis contributes to airway inflammation and remodeling in asthma.
    Allergy. 2022 Jul 20. doi: 10.1111/all.15448.
    >> Share

  155. MAGGI E, Parronchi P, Azzarone BG, Moretta L, et al
    A pathogenic integrated view explaining the different endotypes of asthma and allergic disorders.
    Allergy. 2022 Jul 16. doi: 10.1111/all.15445.
    >> Share

  156. BENAMAR M, Harb H, Chen Q, Wang M, et al
    A Common IL-4 Receptor Variant Promotes Asthma Severity via a Treg Cell GRB2-IL-6-Notch4 Circuit.
    Allergy. 2022 Jul 16. doi: 10.1111/all.15444.
    >> Share

  157. DEVRIES A, McCauley K, Fadrosh D, Fujimura KE, et al
    Maternal Prenatal Immunity, Neonatal Trained Immunity, and Early Airway Microbiota Shape Childhood Asthma Development.
    Allergy. 2022 Jul 16. doi: 10.1111/all.15442.
    >> Share

  158. KIM JG, Zhang A, Rauseo AM, Goss CW, et al
    The nasopharyngeal and salivary microbiomes in COVID-19 patients with and without asthma.
    Allergy. 2022 Jul 15. doi: 10.1111/all.15438.
    >> Share

  159. NAVARATNA S, Burgess J, Waidyatillake N, Peters RL, et al
    Reply to the correspondence: Bacillus Calmette-Guerin vaccination to prevent childhood asthma-A revised analysis.
    Allergy. 2022;77:2264-2265.
    >> Share

  160. PITTET LF, Curtis N
    Bacillus Calmette-Guerin vaccination to prevent childhood asthma: A revised meta-analysis.
    Allergy. 2022;77:2262-2263.
    >> Share

  161. DIVER S, Haldar K, McDowell PJ, Busby J, et al
    Relationship between inflammatory status and microbial composition in severe asthma and during exacerbation.
    Allergy. 2022 Jul 1. doi: 10.1111/all.15425.
    >> Share

  162. LEE SE, Hopkins C, Mullol J, Msihid J, et al
    Dupilumab improves health related quality of life: Results from the phase 3 SINUS studies.
    Allergy. 2022;77:2211-2221.
    >> Share

    June 2022
  163. RADZIKOWSKA U, Baerenfaller K, Cornejo-Garcia JA, Karaaslan C, et al
    Omics technologies in allergy and asthma research: an EAACI position paper.
    Allergy. 2022 Jun 17. doi: 10.1111/all.15412.
    >> Share

  164. CAIT A, Wedel A, Arntz JL, Duinkerken J, et al
    Prenatal antibiotic exposure, asthma and the atopic march: A systematic review and meta-analysis.
    Allergy. 2022 Jun 11. doi: 10.1111/all.15404.
    >> Share

  165. OWORA AH, Li R, Tepper RS, Ramsey CD, et al
    Impact of time-varying confounders on the association between early-life allergy sensitization and the risk of current asthma: a post-hoc analysis of a birth cohort.
    Allergy. 2022 Jun 10. doi: 10.1111/all.15403.
    >> Share

  166. STARK JM, Liu J, Tibbitt CA, Christian M, et al
    A recombinant multimeric dog allergen prevents airway hyperresponsiveness in a model of asthma marked by vigorous TH 2 and TH 17 cell responses.
    Allergy. 2022 Jun 3. doi: 10.1111/all.15399.
    >> Share

    May 2022
  167. OOKA T, Raita Y, Fujiogi M, Freishtat RJ, et al
    Proteomics endotyping of infants with severe bronchiolitis and risk of childhood asthma.
    Allergy. 2022 May 27. doi: 10.1111/all.15390.
    >> Share

  168. ANDIAPPAN AK, Puan KJ, Sio YY, Ally F, et al
    Functional CTLA-4 variants associate to both allergic asthma and rhinitis potentially by modulating naive regulatory T cells.
    Allergy. 2022 May 24. doi: 10.1111/all.15386.
    >> Share

  169. CARRARO S, di Palmo E, Licari A, Barni S, et al
    Metabolomics to identify omalizumab responders among children with severe asthma: a prospective study.
    Allergy. 2022 May 23. doi: 10.1111/all.15385.
    >> Share

  170. KALLIERI M, Zervas E, Fouka E, Porpodis K, et al
    RELIght: A two-year REal-LIfe study of mepolizumab in patients with severe eosinophilic asTHma in Greece: evaluating the multiple components of response.
    Allergy. 2022 May 20. doi: 10.1111/all.15382.
    >> Share

  171. LOMMATZSCH M, Suhling H, Korn S, Bergmann KC, et al
    Safety of combining biologics in severe asthma: asthma-related and unrelated combinations.
    Allergy. 2022 May 18. doi: 10.1111/all.15379.
    >> Share

  172. SOZENER ZC, Cevhertas L, Satitsuksanoa P, van de Veen W, et al
    Innate lymphoid cell subsets in obese asthma patients: Difference in activated cells in peripheral blood and their relationship to disease severity.
    Allergy. 2022 May 18. doi: 10.1111/all.15378.
    >> Share

  173. KHALFAOUI L, Symon FA, Couillard S, Hargadon B, et al
    Airway remodelling rather than cellular infiltration characterises both type2 cytokine biomarker-high and -low severe asthma.
    Allergy. 2022 May 17. doi: 10.1111/all.15376.
    >> Share

  174. ACKLAND J, Barber C, Heinson A, Azim A, et al
    NTHi infection of pulmonary macrophages drives neutrophilic inflammation in severe asthma.
    Allergy. 2022 May 16. doi: 10.1111/all.15375.
    >> Share

  175. XING Y, Wang MH, Leung TF, Wong CK, et al
    Poultry exposure and environmental protection against asthma in rural children.
    Allergy. 2022 May 9. doi: 10.1111/all.15365.
    >> Share

  176. SADLIER C, Albrich WC, Neogi U, Lunjani N, et al
    Metabolic rewiring and serotonin depletion in patients with postacute sequelae of COVID-19.
    Allergy. 2022;77:1623-1625.
    >> Share

    April 2022
  177. POTAPOVA E, Bordas-Le Floch V, Schlederer T, Vrtala S, et al
    Molecular reactivity profiling upon immunotherapy with a 300 IR sublingual house dust mite tablet reveals marked humoral changes towards major allergens.
    Allergy. 2022 Apr 26. doi: 10.1111/all.15327.
    >> Share

  178. FARRAIA M, Paciencia I, Mendes FC, Cavaleiro Rufo J, et al
    Cost-effectiveness analysis of house dust mite allergen immunotherapy in children with allergic asthma.
    Allergy. 2022 Apr 22. doi: 10.1111/all.15321.
    >> Share

  179. VAN DER BURG N, Stenberg H, Bjermer L, Diamant Z, et al
    Cysteinyl-leukotriene and prostaglandin pathways in bronchial versus alveolar lavage in allergic asthmatics.
    Allergy. 2022 Apr 22. doi: 10.1111/all.15319.
    >> Share

  180. HARB H, Chatila TA
    Recent Patents in Allergy/Immunology: Method for treating asthma or allergic disease via anti-Notch4 mAb.
    Allergy. 2022 Apr 19. doi: 10.1111/all.15317.
    >> Share

  181. RASMUSSEN SM, Halvard Hansen ES, Stensrud T, Radon K, et al
    Asthma endotypes in elite athletes: A cross-sectional study of European athletes participating in the Olympic Games.
    Allergy. 2022 Apr 15. doi: 10.1111/all.15313.
    >> Share

  182. WENG N, Miller M, Pham AK, Komor AC, et al
    Single-base editing of rs12603332 on chromosome 17q21 with a cytosine base editor regulates ORMDL3 and ATF6alpha expression.
    Allergy. 2022;77:1139-1149.
    >> Share

  183. MULLOL J, Laidlaw TM, Bachert C, Mannent LP, et al
    Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID-ERD: Results from two randomized placebo-controlled phase 3 trials.
    Allergy. 2022;77:1231-1244.
    >> Share

    March 2022
  184. FARRAIA M, Paciencia I, Castro Mendes F, Cavaleiro Rufo J, et al
    Allergen immunotherapy for asthma prevention: A systematic review and meta-analysis of randomized and non-randomized controlled studies.
    Allergy. 2022 Mar 28. doi: 10.1111/all.15295.
    >> Share

  185. LI Z, Feng Y, Liu H, Yang H, et al
    Single-cell transcriptomics of mouse lung reveal inflammatory memory neutrophils in allergic asthma.
    Allergy. 2022 Mar 21. doi: 10.1111/all.15286.
    >> Share

  186. PAT Y, Ruckert B, Ogulur I, Yazici D, et al
    Differentiation of bronchial epithelial spheroids in the presence of IL-13 recapitulates characteristic features of asthmatic airway epithelia.
    Allergy. 2022 Mar 10. doi: 10.1111/all.15279.
    >> Share

  187. RYAN D, Flokstra-de Blok BM, Clark E, Gaudin C, et al
    Allergic and hypersensitivity conditions in non-specialist care: Flow-diagrams to support clinical practice.
    Allergy. 2022 Mar 10. doi: 10.1111/all.15273.
    >> Share

  188. ZUBERBIER T, Abdul Latiff AH, Abuzakouk M, Aquilina S, et al
    The international EAACI/GA(2)LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria.
    Allergy. 2022;77:734-766.
    >> Share

  189. PAVORD ID, Bel EH, Bourdin A, Chan R, et al
    From DREAM to REALITI-A and beyond: Mepolizumab for the treatment of eosinophil-driven diseases.
    Allergy. 2022;77:778-797.
    >> Share

    February 2022
  190. HAAHTELA T, Jantunen J, Saarinen K, Tommila E, et al
    Managing the allergy & asthma epidemic in 2020s - lessons from the Finnish experience.
    Allergy. 2022 Feb 24. doi: 10.1111/all.15266.
    >> Share

  191. SOKOLOWSKA M, Rovati GE, Diamant Z, Untersmayr E, et al
    Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses. EAACI task force on eicosanoids consensus report in times of COVID-19.
    Allergy. 2022 Feb 16. doi: 10.1111/all.15258.
    >> Share

  192. JUTEL M, Torres MJ, Palomares O, Akdis CA, et al
    COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals - EAACI recommendations.
    Allergy. 2022 Feb 11. doi: 10.1111/all.15252.
    >> Share

  193. SOUSA-PINTO B, Fonseca JA, Gemicioglu B, Regateiro FS, et al
    Patient-reported outcome measures (PROMs) using the MASK-air(R) app in severe asthma.
    Allergy. 2022 Feb 8. doi: 10.1111/all.15248.
    >> Share

  194. TANG X, Ronnberg E, Safholm J, Thulasingam M, et al
    Activation of succinate receptor 1 boosts human mast cell reactivity and allergic bronchoconstriction.
    Allergy. 2022 Feb 4. doi: 10.1111/all.15245.
    >> Share

  195. CERPS S, Sverrild A, Ramu S, Nieto-Fontarigo JJ, et al
    House dust mite sensitization and exposure affects bronchial epithelial anti-microbial response to viral stimuli in patients with asthma.
    Allergy. 2022 Feb 3. doi: 10.1111/all.15243.
    >> Share

  196. FIETEN KB, Drijver-Messelink MT, Cogo A, Charpin D, et al
    Alpine Altitude Climate Treatment for severe and uncontrolled asthma: an EAACI Position Paper.
    Allergy. 2022 Feb 3. doi: 10.1111/all.15242.
    >> Share

  197. HAYA LK, Mehri R, Somers-Neal S, Van de Mosselaer S, et al
    Automated dander dispersal in a cat Naturalistic Exposure Chamber (NEC).
    Allergy. 2022;77:685-687.
    >> Share

    January 2022
  198. PARR CL, Nystad W, Karlstad O, Oymar K, et al
    Ten year trends of national healthcare costs of asthma, allergic rhinitis and atopic eczema in 3 million Norwegians.
    Allergy. 2022 Jan 20. doi: 10.1111/all.15225.
    >> Share

  199. THEOFANI E, Semitekolou M, Samitas K, Mais A, et al
    TFEB signaling attenuates NLRP3-driven inflammatory responses in severe asthma.
    Allergy. 2022 Jan 17. doi: 10.1111/all.15221.
    >> Share

  200. NANISHI M, Fujiogi M, Freishtat RJ, Hoptay CE, et al
    Serum periostin among infants with severe bronchiolitis and risk of developing asthma: A prospective multicenter cohort study.
    Allergy. 2022 Jan 9. doi: 10.1111/all.15216.
    >> Share

  201. HUANG Y, Li X, Zhu L, Huang C, et al
    Thrombin cleaves IL-33 and modulates IL-33-activated allergic lung inflammation.
    Allergy. 2022 Jan 7. doi: 10.1111/all.15210.
    >> Share

  202. AGACHE I, Antolin-Amerigo D, de Blay F, Boccabella C, et al
    EAACI position paper on the clinical use of the bronchial allergen challenge: unmet needs and research priorities.
    Allergy. 2022 Jan 2. doi: 10.1111/all.15203.
    >> Share

    December 2021
  203. SOUSA-PINTO B, Filipe Azevedo L, Jutel M, Agache I, et al
    Development and validation of combined symptom-medication scores for allergic rhinitis.
    Allergy. 2021 Dec 21. doi: 10.1111/all.15199.
    >> Share

  204. CORREN J, Pham TH, Gil EG, Salapa K, et al
    Baseline type 2 biomarker levels and response to tezepelumab in severe asthma.
    Allergy. 2021 Dec 16. doi: 10.1111/all.15197.
    >> Share

  205. JANSEN K, Satitsuksanoa P, Wirz OF, Schneider SR, et al
    T regulatory cells from atopic asthmatic individuals show a Th2-like phenotype.
    Allergy. 2021 Dec 4. doi: 10.1111/all.15193.
    >> Share

    November 2021
  206. DELGADO-DOLSET MI, Obeso D, Rodriguez-Coira J, Tarin C, et al
    Understanding uncontrolled severe allergic asthma by integration of omic and clinical data.
    Allergy. 2021 Nov 28. doi: 10.1111/all.15192.
    >> Share

  207. MISHRA A, Majid D, Kandikattu HK, Yadavalli CS, et al
    Role of IL-18 transformed CD274-expressing eosinophils in promoting airway obstruction in experimental asthma.
    Allergy. 2021 Nov 20. doi: 10.1111/all.15180.
    >> Share

    October 2021
  208. LUNDING LP, Skouras DB, Vock C, Dinarello CA, et al
    The NLRP3 Inflammasome Inhibitor, OLT1177((R)) , Ameliorates Experimental Allergic Asthma in Mice.
    Allergy. 2021 Oct 30. doi: 10.1111/all.15164.
    >> Share

  209. CHANTVEERAWONG T, Sangkangjanavanich S, Chiewchalermsri C, Pradubpongsa P, et al
    Increased circulating CRTH2(+) Tregs are associated with asthma control and exacerbation.
    Allergy. 2021 Oct 22. doi: 10.1111/all.15145.
    >> Share

  210. SOUSA-PINTO B, Anto JM, Sheikh A, de Lusignan S, et al
    Comparison of epidemiologic surveillance and Google Trends data on asthma and allergic rhinitis in England.
    Allergy. 2021 Oct 19. doi: 10.1111/all.15139.
    >> Share

  211. ADJIBADE M, Davisse-Paturet C, Bernard JY, Adel-Patient K, et al
    Enrichment of infant formula with long-chain polyunsaturated fatty acids and risk of infection and allergy in the nationwide ELFE birth cohort.
    Allergy. 2021 Oct 9. doi: 10.1111/all.15137.
    >> Share

  212. PAPI A, Jesenak M, Alfano F, Peroni DG, et al
    The ICQ Asthma Algorithm: Inhaled corticosteroid Containing resCUE (ICQ) treatment for present and future asthma management.
    Allergy. 2021 Oct 6. doi: 10.1111/all.15131.
    >> Share

  213. GERTH VAN WIJK R, Dahl R
    Pros and cons: Should AIT be considered in all patients with allergic asthma?
    Allergy. 2021 Oct 4. doi: 10.1111/all.15123.
    >> Share

  214. SMITH AM, Ramirez RM, Harper N, Jimenez F, et al
    Large-scale provocation studies identify maladaptive responses to ubiquitous aeroallergens as a correlate of severe allergic rhinoconjunctivitis and asthma.
    Allergy. 2021 Oct 4. doi: 10.1111/all.15124.
    >> Share

  215. KIM JM, Im YN, Chung YJ, Youm JH, et al
    Glutamine deficiency shifts the asthmatic state toward neutrophilic airway inflammation.
    Allergy. 2021 Oct 3. doi: 10.1111/all.15121.
    >> Share

    September 2021
  216. KIM YC, Choi S, Sohn KH, Bang JY, et al
    Selenomonas: a marker of asthma severity with the potential therapeutic effect.
    Allergy. 2021 Sep 29. doi: 10.1111/all.15114.
    >> Share

  217. RAIFER H, Schulz AR, Theodorou J, Romero-Olmedo AJ, et al
    Mass cytometry-based identification of a unique T-cell signature in childhood allergic asthma.
    Allergy. 2021 Sep 26. doi: 10.1111/all.15110.
    >> Share

  218. KHALEVA E, Knibb R, DunnGalvin A, Vazquez-Ortiz M, et al
    Perceptions of adolescents and young adults with allergy and/or asthma and their parents on EAACI guideline recommendations about transitional care: A European survey.
    Allergy. 2021 Sep 26. doi: 10.1111/all.15109.
    >> Share

    August 2021
  219. JANTUNEN J, Kauppi P, Linna M, Makela M, et al
    Real-world evidence of reduced disability costs during the Finnish Allergy Programme 2008-2018.
    Allergy. 2021 Aug 30. doi: 10.1111/all.15070.
    >> Share

  220. SCHRODER A, Lunding LP, Zissler UM, Vock C, et al
    IL-37 regulates allergic inflammation by counterbalancing pro-inflammatory IL-1 and IL-33.
    Allergy. 2021 Aug 30. doi: 10.1111/all.15072.
    >> Share

  221. TRAMPER-STRANDERS G, Ambrozej D, Arcolaci A, Atanaskovic-Markovic M, et al
    Dangerous liaisons: bacteria, antimicrobial therapies and allergic diseases.
    Allergy. 2021 Aug 13. doi: 10.1111/all.15046.
    >> Share

    June 2021
  222. GIANG N, Mars M, Moreau M, Mejia JE, et al
    Separation of the CaV 1.2-CaV 1.3 calcium channel duo prevents type-2 allergic airway inflammation.
    Allergy. 2021 Jun 28. doi: 10.1111/all.14993.
    >> Share

  223. SIROUX V, Boudier A, Bousquet J, Dumas O, et al
    Trajectories of IgE sensitization to allergen molecules from childhood to adulthood and respiratory health in the EGEA cohort.
    Allergy. 2021 Jun 25. doi: 10.1111/all.14987.
    >> Share

    May 2021
  224. PFAAR O, Bergmann KC, Bonini S, Compalati E, et al
    Technical standards in allergen exposure chambers worldwide - an EAACI Task Force Report.
    Allergy. 2021 May 24. doi: 10.1111/all.14957.
    >> Share

  225. VENTER C, Palumbo MP, Glueck DH, Sauder KA, et al
    The Maternal Diet Index in Pregnancy is associated with offspring allergic diseases: The Healthy Start Study.
    Allergy. 2021 May 21. doi: 10.1111/all.14949.
    >> Share

  226. THURMANN L, Herberth G, Seiwert B, Schlittenbauer L, et al
    Prenatal paraben exposure and atopic dermatitis-related outcomes among children.
    Allergy. 2021 May 2. doi: 10.1111/all.14890.
    >> Share

    April 2021
  227. HEMMER W, Sestak-Greinecker G, Braunsteiner T, Wantke F, et al
    Molecularsensitization patterns in animal allergy: relationship with clinical relevance and pet ownership.
    Allergy. 2021 Apr 29. doi: 10.1111/all.14885.
    >> Share

  228. MINDAYE ST, Sun C, Esfahani SAZ, Matsui EC, et al
    Diversity and complexity of mouse allergens in urine, house dust, and allergen extracts assessed with an immuno-allergomic approach.
    Allergy. 2021 Apr 17. doi: 10.1111/all.14860.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016